From: Protein biomarkers in cervicovaginal lavages for detection of endometrial cancer
Characteristics | n (%) | |
---|---|---|
Histological type (n = 66) | Endometrioid adenocarcinoma | 33 (50.0) |
Endometrioid carcinoma | 26 (39.4) | |
Serous carcinoma | 4 (6.1) | |
Other | 3 (4.5) | |
FIGO stage (n = 62) | I | 1 (1.6) |
IA | 43 (69.4) | |
IB | 10 (16.1) | |
II | 2 (3.2) | |
IIIC | 4 (6.5) | |
IV | 2 (3.2) | |
Tumor grade (n = 66) | Grade 1 | 42 (63.6) |
Grade 2 | 15 (22.7) | |
Grade 3 | 9 (13.6) | |
Size (n = 62) | ≤ 2 cm | 17 (27.4) |
> 2 cm | 45 (72.6) | |
Myometrial invasion (n = 66) | no | 20 (30.3) |
yes | 46 (69.7) | |
depth reported | 40 (60.6) | |
depth not reported | 6 (9.1) | |
Lymphovascular invasion (n = 65) | no | 61 (93.8) |
yes | 4 (6.2) | |
MMR protein status (n = 60) | MMR-proficient | 46 (76.7) |
MMR-deficient | 14 (23.3) | |
Loss of nuclear expression | MLH1 | 9 (15.0) |
PMS2 | 11 (18.3) | |
MSH2 | 1 (1.7) | |
MSH6 | 4 (6.7) |